Clinical Trials on Bone Metastases in Men With Hormone-Refractory Prostate Cancer
Total 332 results
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast CancerSpain, Czechia, Peru, Russian Federation, Austria, Lithuania, Poland, South Africa, Italy, Ukraine, Israel, Argentina, Belgium, Brazil, France, Hungary, Japan, Latvia, Panama
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer | Bone Metastases in Subjects With Advanced Cancer or Multiple MyelomaUnited Kingdom, Czech Republic
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer | Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
-
BayerCompletedBone Metastases | Hormone Refractory Prostate CancerItaly, Spain, Hong Kong, Canada, United Kingdom, France, Australia, United States, Germany, Brazil, Israel, Netherlands, Norway, Belgium, Sweden, Czech Republic, Poland, Singapore, Slovakia
-
BayerCompletedBone Metastases | Hormone Refractory Prostate Cancer
-
Novartis PharmaceuticalsCompletedProstate Cancer Patients With Bone Metastasis
-
Novartis PharmaceuticalsCompletedProstate Cancer With Bone Metastasis
-
The University of Texas Health Science Center,...CompletedBony Metastases From Castrate Refractory Prostate CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Bone Metastases | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Soft Tissue MetastasesUnited States
-
Alberta Health servicesAmersham Health; The Prostate Cancer Research Foundation of CanadaCompletedBone Metastases | Hormone Refractory Prostate CancerCanada
-
AmgenCompletedHormone Refractory Prostate Cancer
-
Novartis PharmaceuticalsCompletedProstate Cancer With at Least One Bone Lesion in Patients Receiving Hormonal Therapy and Treatment With Bisphosphonates is Indicated
-
Zhujiang HospitalRecruitingProstate Cancer With ≤10 Bone MetastasesChina
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Bone Metastases | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of Colorado, DenverCompletedBone Metastases | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Soft Tissue MetastasesUnited States
-
University of ChicagoNorthShore University HealthSystemCompletedRecurrent Prostate Cancer | Bone Metastases | Stage IV Prostate Cancer | Castrate-resistant Prostate CancerUnited States
-
Amorphical Ltd.WithdrawnCastrate Resistant Prostate Cancer With Bone MetastasisIsrael
-
Taro Iguchi, MD, PHDBayer Yakuhin, Ltd.Active, not recruitingBone Metastases | Castration-resistant Prostate CancerJapan
-
Institut Cancerologie de l'OuestAstraZenecaActive, not recruitingBone Metastases | Prostate Cancer Patients | Node; ProstateFrance
-
Cancer Trials IrelandTerminatedMetastatic Cancer | Bone Metastases | Castration-resistant Prostate CancerIreland
-
British Columbia Cancer AgencyCanadian Institutes of Health Research (CIHR)Completed
-
University of California, San FranciscoCompletedMen With Prostate Cancer Undergoing Robot Assisted Radical ProstatectomyUnited States
-
BayerCompletedBone Metastases | Castration-Resistant Prostate CancerUnited States, France
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedBone Metastases | Cancer Survivor | Metastatic Malignant Neoplasm in the BoneUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Bone Metastases | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Ajjai Alva, MDHoosier Cancer Research Network; Bayer Healthcare Pharmaceuticals, Inc./Bayer...TerminatedProstate Cancer | Bone Metastases | Prostate NeoplasmsUnited States
-
Sandy SrinivasWyeth is now a wholly owned subsidiary of Pfizer; American Society of Clinical... and other collaboratorsTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
Institut du Cancer de Montpellier - Val d'AurelleCompletedProstate Cancer | Bone Metastases | Hormone-resistant Prostate CancerFrance
-
Stanford UniversityTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
AmgenCompletedBreast Cancer | Metastases | Bone Metastases in Subjects With Advanced Breast Cancer
-
Assistance Publique Hopitaux De MarseilleUnknownAny Cancer With Multiple Bone MetastasesFrance
-
iOMEDICO AGCompletedBreast Cancer | Prostate Cancer | Bone MetastasesGermany
-
Novartis PharmaceuticalsCompletedBreast Cancer | Prostate Cancer | Bone MetastasisGermany
-
Valentina GaribottoUniversity Hospital, GenevaCompletedProstate Cancer | Bone MetastasesSwitzerland
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Hormone-Resistant Prostate CancerUnited States
-
The Netherlands Cancer InstituteBayerCompletedBone Metastases | Prostate Cancer MetastaticNetherlands
-
Roswell Park Cancer InstituteDendreonCompletedMetastatic Malignant Neoplasm in the Bone | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm in the Bone | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
University of California, IrvineBristol-Myers SquibbCompletedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Hormone-refractory Prostate CancerUnited States
-
Novartis PharmaceuticalsTerminatedProstate Cancer | Bone MetastasesUnited States
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingMetastatic Breast Cancer | Bone Metastases | Metastatic Prostate CancerSwitzerland, Germany, Austria
-
AmgenCompleted
-
Azienda Socio Sanitaria Territoriale degli Spedali...RecruitingProstate Cancer | Bone MetastasesItaly
-
Milton S. Hershey Medical CenterCompletedEffect of Selenium on Oxidative Stress in Healthy MenUnited States
-
National Cancer Institute (NCI)TerminatedKetoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate CancerRecurrent Prostate Cancer | Bone Metastases | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
ImmuniconUnknownProstate Cancer | Hormone Refractory Prostate CancerUnited States
-
DendreonCompletedHormone Refractory Prostate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bayer; Janssen, LP; Prostate Cancer Clinical Trials ConsortiumCompletedStage IV Prostate Adenocarcinoma | Hormone-refractory Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
A. Vogel AGUniversity of LondonUnknownSexual Dysfunctions in Men With Benign Prostatic HyperplasiaSwitzerland
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHormone Refractory Prostate Cancer | Metastatic Prostate CarcinomaChina